close_game
close_game

Centre approves Sputnik booster shot, says official

By, Hindustan Times, New Delhi
May 07, 2022 06:37 AM IST

“Details should be firmed-up soon, and the process should also begin at the earliest to ensure that people who have taken Sputnik V will get their booster dose,” said the person quoted above, on the condition of anonymity, adding, that it could be a matter of a few weeks.

With the Centre giving a go-ahead for Sputnik Light to be used as a booster dose, nearly 650,000 people who took the first dose of Sputnik V will now be able to access the vaccine at private vaccination centres, people familiar with the matter said on Friday.

A medical specialist holds a vial of Sputnik V vaccine against Covid-19. (REUTERS)
A medical specialist holds a vial of Sputnik V vaccine against Covid-19. (REUTERS)

“Details should be firmed-up soon, and the process should also begin at the earliest to ensure that people who have taken Sputnik V will get their booster dose,” said the person quoted above, on the condition of anonymity, adding, that it could be a matter of a few weeks.

Stay tuned with breaking news on HT Channel on Facebook. Join Now

Pharma company Dr Reddy’s Laboratories, which has the rights for marketing and distribution to the Russian anti-Covid vaccine in India, has started discussions with the manufacturing partners, hospitals, and also with the government to make the option available on the CoWIN platform.

“This week, component 1 of Sputnik V (or Sputnik Light) was approved for administration at private centres as the precaution dose for those who received Sputnik V as their primary vaccine. Having now received official confirmation of the approval, we are working with manufacturing partners in India...,” said Dr Reddy’s statement.

“Last year, the initial doses landed from Russia but for booster doses, Indian manufacturers that Russian Direct Investment Fund (RDIF) has partnered with will be asked to produce the requisite doses. The volume isn’t huge; therefore all might not be asked to manufacture,” said the person, requesting anonymity.

Get Latest India News along with Latest News and Top Headlines from India and around the world
SHARE THIS ARTICLE ON
  • ABOUT THE AUTHOR
    author-default-90x90

    Rhythma Kaul works as an assistant editor at Hindustan Times. She covers health and related topics, including ministry of health and family welfare, government of India.

SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Tuesday, December 12, 2023
Start 14 Days Free Trial Subscribe Now